EntryPoint Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $385K | Sell |
10,575
-407
| -4% | -$14.8K | 0.19% | 181 |
|
|
2025
Q1 | $398K | Buy |
10,982
+4,043
| +58% | +$146K | 0.18% | 189 |
|
|
2024
Q4 | $292K | Buy |
+6,939
| New | +$292K | 0.12% | 383 |
|
|
2024
Q3 | – | Sell |
-2,531
| Closed | -$104K | – | 1037 |
|
|
2024
Q2 | $104K | Buy |
2,531
+2,257
| +824% | +$92.8K | 0.15% | 301 |
|
|
2024
Q1 | $12.8K | Buy |
+274
| New | +$12.8K | 0.01% | 1187 |
|